Changes to the Revolving Door: Trump’s Ethics Executive Order
Client Alert | less than 1 min read | 01.30.17
On January 28, 2017, President Trump issued an executive order setting forth the ethics restrictions for its executive agency appointees. These restrictions, discussed more fully in our blog post, are simultaneously more restrictive and less restrictive than their 2009 Obama counterparts, and appear to be more focused on appointees’ conduct following their exit from Government rather than on their conduct preceding and during their appointments.
Contacts
Insights
Client Alert | 8 min read | 04.17.26
CMS Finalizes CY 2027 Medicare Advantage and Part D Rule: Key Implications for Plan Sponsors
On April 6, 2026, the Centers for Medicare & Medicaid Services (CMS) published its final rule governing the Medicare Advantage (Part C) and Prescription Drug Benefit (Part D) programs for Contract Year (CY) 2027. The final rule is effective June 1, 2026, with most provisions applicable to coverage beginning January 1, 2027, and marketing and communications changes taking effect October 1, 2026. Beyond payment, the rule pursues a broad deregulatory agenda aligned with Executive Order 14192, reversing marketing and enrollment safeguards introduced in 2023 and easing documentation and reporting obligations, while introducing new program integrity requirements.
Client Alert | 3 min read | 04.17.26
Client Alert | 2 min read | 04.16.26
Client Alert | 4 min read | 04.16.26
ROI Tracking as Mens Rea? Novartis Ruling Reframes AKS Pleading Risk
